How did BBH's Momentum indicator behave recently?

The Momentum Indicator moved above the 0 level on November 05, 2025. You may want to consider a long position or call options on BBH as a result. In 72 of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 81%.

What does a 3-day price advance indicate for BBH?

Following a +0.72% 3-day Advance, the price is estimated to grow further. Considering data from situations where BBH advanced for three days, in 267 of 324 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

BBH

AS OF

Dec 3, 04:59 PM (EDT)

Price

$197.23

Change

+$2.90 (+1.49%)

Net Assets

385.76M

Intraday BUY SELL Signals

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

+Compare

BBH

ETF ticker: NASDAQ

AS OF

Dec 3, 04:59 PM (EDT)

Price

$197.23

Change

+$2.90 (+1.49%)

Net Assets

385.76M

BBH stock forecast, quote, news & analysis

Q: How does the Aroon Indicator reflect on BBH's trend?

The Aroon Indicator entered an Uptrend today. In 207 of 256 cases where BBH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 81%.

The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® U... Show more

Category: #Health

Get AI intraday signals

BBH

Setup

Daily Signal:

Description

Gain/Loss:

A.I.Advisor

published price charts

These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.

View AI-Driven Trading for BBH

Interact to see
Advertisement

A.I.Advisor

a Summary for BBH with price predictions

Nov 28, 2025

BBH's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for BBH turned positive on November 10, 2025. Looking at past instances where BBH's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 05, 2025. You may want to consider a long position or call options on BBH as a result. In of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BBH advanced for three days, in of 324 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 256 cases where BBH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 12 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 19 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BBH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BBH broke above its upper Bollinger Band on November 11, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor

published Highlights

Notable companies

The most notable companies in this group are Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Regeneron Pharmaceuticals (NASDAQ:REGN), IQVIA Holdings (NYSE:IQV), Biogen (NASDAQ:BIIB), Incyte Corp (NASDAQ:INCY), Illumina (NASDAQ:ILMN), Exact Sciences Corp (NASDAQ:EXAS), Moderna (NASDAQ:MRNA), Intra-Cellular Therapies (NASDAQ:ITCI).

Industry description

The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® U.S. Listed Biotech 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

Market Cap

The average market capitalization across the VanEck Biotech ETF ETF is 39.29B. The market cap for tickers in the group ranges from 2.07B to 181.73B. AMGN holds the highest valuation in this group at 181.73B. The lowest valued company is SRPT at 2.07B.

High and low price notable news

The average weekly price growth across all stocks in the VanEck Biotech ETF ETF was 7%. For the same ETF, the average monthly price growth was 51%, and the average quarterly price growth was 181%. ALNY experienced the highest price growth at 8%, while REGN experienced the biggest fall at -6%.

Volume

The average weekly volume growth across all stocks in the VanEck Biotech ETF ETF was -59%. For the same stocks of the ETF, the average monthly volume growth was -67% and the average quarterly volume growth was -58%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 69

P/E Growth Rating: 51

Price Growth Rating: 37

SMR Rating: 69

Profit Risk Rating: 66

Seasonality Score: 9 (-100 ... +100)

View a ticker or compare two or three

Compare

BBH

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I. Advisor

published General Information

General Information

Category Health

Profile

Fundamentals

Details